PHARMAX LIFESCIENCES

Feature

• Refresh Liquigel Eye Gel® (15 mL) is a soothing, lubricant ophthalmic gel designed to relieve chronic dry eye discomfort. Containing 1% carboxymethylcellulose sodium and stabilized Purite preservative, it mimics natural tears for long‑lasting relief from burning, irritation, and environmental stress like wind, sun, air‑conditioning, or extended screen time

Feature

• Careprost is a sterile ophthalmic solution containing Bimatoprost 0.03% w/v, primarily indicated for treating open-angle glaucoma and ocular hypertension by enhancing aqueous humor outflow and reducing intraocular pressure

Feature

• Travatan® is a sterile ophthalmic solution containing Travoprost 0.004%, a prostaglandin analog used to lower intraocular pressure in patients with open‑angle glaucoma or ocular hypertension. By increasing the outflow of aqueous humor, it helps reduce the risk of optic nerve damage and vision loss. The recommended dosage is one drop in the affected eye(s) once daily in the evening. Common side effects include eye redness, eye irritation, and changes in eye color. Patients should remove contact lenses before application and wait at least 15 minutes before reinsertion. Consult a healthcare provider before use

Feature

• Combigan is a sterile ophthalmic solution combining Brimonidine Tartrate 0.2% w/v, an alpha‑2 adrenergic agonist, with Timolol Maleate 0.5% w/v, a non‑selective beta‑blocker. This dual-action eye drop provides enhanced reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension by simultaneously decreasing aqueous humor production and increasing uveoscleral outflow . Administered as one drop in each affected eye twice daily (approx. every 12 hours)

Feature

• Brimonidine Tartrate Ophthalmic Solution 5 mL – 100-Word Feature
• Brimonidine Tartrate Ophthalmic Solution (5 mL) is an effective anti-glaucoma medication used to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It contains Brimonidine Tartrate 0.2% w/v, an alpha-2 adrenergic agonist that decreases aqueous humor production and increases uveoscleral outflow, lowering eye pressure. The solution is sterile, well-tolerated, and typically applied twice daily. It provides a rapid onset of action with minimal systemic absorption. Packaged in a convenient dropper bottle, it allows accurate, hygienic dosing. Side effects may include mild eye redness, dryness, or itching. Regular use helps prevent optic nerve damage and vision loss.

Feature
Bimatoprost Ophthalmic Solution 0.03% (3 mL) is a sterile, isotonic, colorless eye drop formulated with 0.3 mg/mL bimatoprost and 0.05 mg/mL benzalkonium chloride preservative

• Dorzox 5 mL is a sterile ophthalmic solution containing Dorzolamide 2%, a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. By inhibiting the enzyme carbonic anhydrase II in the ciliary body, Dorzox reduces the production of aqueous humor, thereby decreasing eye pressure. Common side effects include stinging or burning sensations, blurred vision, and a bitter taste. It is contraindicated in patients with severe kidney dysfunction or hypersensitivity to sulfonamides. Pregnant and breastfeeding women should consult a healthcare provider before use

• Dorzox-T Eye Drops (Dorzolamide & Timolol) – 100 Words Feature
• Dorzox-T Eye Drops combine Dorzolamide Hydrochloride and Timolol Maleate, formulated to effectively reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Dorzolamide, a carbonic anhydrase inhibitor, decreases aqueous humor production, while Timolol, a beta-blocker, complements this action by further reducing fluid formation. Together, they provide enhanced pressure-lowering efficacy compared to monotherapy. The sterile ophthalmic solution is well-tolerated, easy to administer, and offers twice-daily dosing convenience. Dorzox-T complies with IP standards, ensuring safety, potency, and purity. Its dual-action formula helps protect the optic nerve and prevent vision loss in glaucoma patients when used regularly as prescribed.

Feature

• Restasis is a sterile ophthalmic emulsion containing cyclosporine 0.05% w/v, designed to treat moderate to severe dry eye disease (keratoconjunctivitis sicca) associated with ocular inflammation. It works by suppressing local immune activity in the lacrimal gland, reducing inflammation and thereby increasing natural tear production

• Ciplox Eye/Ear Drops – 100 Words Feature
• Ciplox Eye/Ear Drops contain Ciprofloxacin Hydrochloride, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of bacterial infections. Designed for topical ophthalmic and otic use, it is ideal for treating bacterial conjunctivitis, corneal ulcers, and ear infections such as otitis externa. The sterile solution ensures targeted action with minimal systemic absorption. Ciplox inhibits bacterial DNA gyrase, preventing replication and promoting rapid healing. It is well-tolerated, easy to administer, and comes in a convenient dropper bottle for accurate dosing. Ciplox Eye/Ear Drops meet IP/BP/USP quality standards, offering safe, reliable, and effective infection control in both eye and ear applications.

Feature

• Ciplox‑D Eye/Ear Drops (10 mL) from Cipla combine ciprofloxacin (0.3% w/v), a broad‑spectrum fluoroquinolone antibiotic, with dexamethasone (0.1% w/v), a potent corticosteroid. This sterile, dual-purpose solution effectively treats bacterial eye infections (e.g. conjunctivitis, corneal ulcers) and ear infections (e.g. otitis externa), while reducing inflammation, pain, redness, and swelling